Patents-Review.com
ClassID:

21482 ⎘

A61K49/105 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA

Recent Application in this class:
#1
20250271525
2025-08-28

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

 #2
20250120975
2025-04-17

INTEGRIN INHIBITORS FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS

 #3
20250057989
2025-02-20

TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS

 #4
20250045926
2025-02-06

DETECTION OF ARTIFACTS IN SYNTHETIC IMAGES

 #5
20240404255
2024-12-05

GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES

 #6
20240277874
2024-08-22

FLUORESCENCE-MAGNETIC RESONANCE DUAL-MODALITY CONTRAST AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF

 #7
20240138701
2024-05-02

DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE

 #8
20230405115
2023-12-21

COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)

 #9
20220387557
2022-12-08

TNF MUTEINS AND USES THEREOF

 #10
20220211879
2022-07-07

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

 #11
20210298611
2021-09-30

DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE

 #12
20210244830
2021-08-12

TMEM-MCD IN THE MINIMALLY INVASIVE ASSESSMENT OF THE ACTIVITY STATUS OF TMEM IN ITS DISSEMINATION OF TUMOR CELLS

 #13
20200371183
2020-11-26

Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

 #14
20200323897
2020-10-15

METHODS FOR DISTRIBUTING AGENTS TO AREAS OF BRAIN

 #15
20200271586
2020-08-27

ULTRA-SENSITIVE DETECTION METHOD USING PHOTOLUMINESCENT PARTICLES

 #16
20200158803
2020-05-21

Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)

 #17
20200108155
2020-04-09

Ultrafine nanoparticles as multimodal contrast agent

 #18
20190381195
2019-12-19

Conjugated polymer-based nanoprobe and preparation method and application thereof

 #19
20190365933
2019-12-05

Solvent-free gadolinium contrast agents

 #20
20190282713
2019-09-19

Imaging compositions

 #21
20190271677
2019-09-05

Methods and kits for detecting non-luminescent or weakly luminescent metals

 #22
20190269805
2019-09-05

SOLVENT-FREE GADOLINIUM CONTRAST AGENTS

 #23
20190094323
2019-03-28

SYSTEMS AND METHODS OF DETECTING INTERSTITIAL CYSTITIS

 #24
20180303960
2018-10-25

Combination formulation

 #25
20180214582
2018-08-02

METHOD FOR DIAGNOSING CARCINOMAS USING IRGD AND MAGENTIC RESONANCE TOMOGRAPHY (MRT)

 #26
20170074859
2017-03-16

Graphene oxide mediated cellular delivery of gadolinium-labeled molecules

 #27
20160166507
2016-06-16

NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES

 #28
20160008496
2016-01-14

Imaging diagnostics by combining contrast agents

 #29
20150346304
2015-12-03

Cardiac late gadolinium enhancement MRI for patients with implanted cardiac devices

 #30
20150283272
2015-10-08

Dual mode gadolinium nanoparticle contrast agents

 #31
20150050217
2015-02-19

Ultrafine nanoparticles as multimodal contrast agent

 #32
20150005483
2015-01-01

GO-GD-DTPA COMPLEX, PREPARATION METHOD THEREOF, AND MRI CONTRAST AGENT COMPRISING THE SAME

 #33
20140065076
2014-03-06

CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME

 #34
20140065075
2014-03-06

TARGETED CONTRAST AGENTS AND USES THEREOF

 #35
20130224113
2013-08-29

Imaging diagnostics by combining contrast agents

 #36
20130142735
2013-06-06

In Vivo Mitochondrial Labeling Using Positively-CHarged Nitroxide Enhanced and Gadolinum Chelate Enhanced Magnetic Resonance Imaging

 #37
20120238865
2012-09-20

Method for Measuring the Physiological Parameters of Brain Interstitial Fluid and Brain Extracellular Space

 #38
20120128583
2012-05-24

DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME

 #39
20120087869
2012-04-12

Methods for distributing agents to areas of brain

 #40
20110243847
2011-10-06

IMAGING DIAGNOSTICS BY COMBINING CONTRAST AGENTS

 #41
20110166444
2011-07-07

MRI-VISIBLE SUTURES FOR MINIMALLY INVASIVE IMAGE-GUIDED ANASTOMOSIS

 #42
20110150777
2011-06-23

Magnetic resonance tomography imaging

 #43
20110129421
2011-06-02

MATRIX METALLOPROTEASE TARGETING NUCLEIC ACIDS

 #44
20110117015
2011-05-19

Diagnostic agents selective against metalloproteases

 #45
20110054295
2011-03-03

MEDICAL IMAGE DIAGNOSTIC APPARATUS AND METHOD USING A LIVER FUNCTION ANGIOGRAPHIC IMAGE, AND COMPUTER READABLE RECORDING MEDIUM ON WHICH IS RECORDED A PROGRAM THEREFOR

 #46
20100278997
2010-11-04

Preparation for restenosis prevention

 #47
20100278744
2010-11-04

Preparation for restenosis prevention

 #48
20100278737
2010-11-04

Organic-inorganic hybrid particles containing contrast agent

 #49
20100143241
2010-06-10

Method and apparatus for delivery of agents across the blood brain barrier

 #50
20090214437
2009-08-27

In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging

 #51
20080102034
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #52
20080102033
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #53
20060115431
2006-06-01

Procedures of cellular labelling with paramagnetic complexes for mri applications

 #54
20050265922
2005-12-01

Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof

 #55
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

 #56
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis